Bupropion + Naltrexone Tablets
8/90mg
Formulated to target appetite centres in the brain, this combination is utilized to support weight management and alleviate persistent hunger sensations.
Weight Management Medications
Weight management medicines support clinically guided weight reduction through appetite, absorption, or metabolic pathways. This category is most useful when you compare eligibility, mechanism, monitoring, and what happens alongside diet and activity changes.
Clenbuterol Tablets
40 · 60mcg
Historically indicated for bronchial conditions, this compound is utilized to target beta-2 receptors, though not clinically approved for weight management in the UK.
Contrave
8/90mg
Designed to target appetite regulation, this product is utilized to support weight control and alleviate behaviours associated with overeating.
Orlistat Tablets
60 · 120mg
Developed to target weight management, indicated to support dietary efforts to reduce body weight by inhibiting the digestion of dietary fats.
Rybelsus
3 · 7 · 14mg
Indicated to manage type 2 diabetes and developed to support blood sugar control and alleviate weight-related health risks in patients.
Semaglutide Tablets
3 · 7 · 14mg
Formulated to manage type 2 diabetes mellitus and to support weight loss by mimicking natural hormones to regulate blood sugar and appetite levels.
What this category helps you sort out
Body weight is influenced by biology, environment, medicines, sleep, hormones, mental health, pain, and access to food and movement. Medicines can help selected patients, but they are not a stand-alone fix.
Different medicines reduce calorie absorption, change appetite signalling, or affect glucose-related pathways. The right option depends on BMI, weight-related conditions, contraindications, previous attempts, and monitoring capacity.
How to compare options
- Identify the mechanism: appetite regulation, fat absorption reduction, or glucose-related metabolic support.
- Check eligibility criteria, expected review points, and when treatment should be stopped if not effective.
- Review pregnancy plans, pancreatitis history, gallbladder disease, eating-disorder history, kidney disease, and diabetes medicines.
- Look at practical issues: injection technique, gastrointestinal effects, vitamin supplementation, and supply continuity.
Common medication groups
Fat absorption reducers
These medicines reduce absorption of dietary fat and can cause oily stools or urgency if meals are high in fat. Fat-soluble vitamin timing may matter.
Appetite and incretin-pathway medicines
Some medicines affect appetite and fullness through gut-brain hormone pathways. Nausea, dose escalation, gallbladder symptoms, and diabetes medicine interactions are common checks.
Metabolic support medicines
Medicines developed for diabetes may also affect weight in selected patients. Suitability depends on glucose status, kidney function, and overall risk.
Safety notes for this category
Seek medical advice for severe abdominal pain, persistent vomiting, dehydration, symptoms of gallbladder disease, low blood sugar, or pregnancy.
Weight medicines should be reviewed alongside nutrition, physical activity, sleep, mental health, and medicines that may cause weight gain.
Important Safety Information
Weight management medicines differ in eligibility, mechanism, monitoring, and stopping rules. This page is educational and does not replace clinical assessment, nutrition support, or product-specific labeling.